ClinicalTrials.Veeva

Menu

Beta-alanine and Elder Endurance

University of Miami logo

University of Miami

Status

Completed

Conditions

Physical Endurance

Treatments

Behavioral: Muscular endurance exercise
Dietary Supplement: Placebo
Dietary Supplement: Beta-alanine

Study type

Interventional

Funder types

Other

Identifiers

NCT02821481
20140412

Details and patient eligibility

About

The purpose for this study is to determine if beta-alanine supplementation combined with endurance-based resistance training can increase gains in muscular endurance to a greater extent than endurance-based resistance-training alone in older adults.

Enrollment

27 patients

Sex

All

Ages

60 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 60-90 years of age
  • Living independently (not residing in an assisted living facility)
  • Through testing are found not to have sarcopenia
  • Gait speed > 1 m/s
  • Skeletal Muscle Index > 37% in men and > 27.6 % in women
  • Exclusion Criteria
  • Responding with a "yes" to any question on the PAR-Q.
  • Are currently pregnant, or plan to try and become pregnant during the study
  • Functional impairments that could impede the person's ability to participate in a resistance training program
  • Current or recent use of supplements (within the past 3 months for non-alanine containing supplements or one year for supplements containing beta-alanine). Individuals taking only basic multivitamins (without any herbal co-ingredients) may still be allowed to participate. These situations will be reviewed on a case-by-case basis.
  • Are currently enrolled in a regular exercise program (more than once per week)
  • Current or recent smoker
  • Use of medication containing corticosteroids
  • Mini-mental score of 21 or below
  • Severe musculoskeletal impairment
  • Uncontrolled chronic disease
  • Major depression
  • Severe vestibular problems

Exclusion criteria

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

27 participants in 4 patient groups, including a placebo group

Beta-alanine and muscular endurance exercise
Experimental group
Description:
Receive 3.2 g/day beta-alanine and 3 days per week of endurance resistance training for 12 weeks
Treatment:
Dietary Supplement: Beta-alanine
Behavioral: Muscular endurance exercise
Beta-alanine without muscular endurance training
Experimental group
Description:
Receive 3.2 g/day beta-alanine with no endurance resistance training for 12 weeks
Treatment:
Dietary Supplement: Beta-alanine
Placebo and muscular endurance exercise
Placebo Comparator group
Description:
Receive similar dextrose placebo and 3 days per week of endurance resistance training for 12 weeks
Treatment:
Dietary Supplement: Placebo
Behavioral: Muscular endurance exercise
Placebo without muscular endurance training
Placebo Comparator group
Description:
Receive similar dextrose placebo with no endurance resistance training for 12 weeks
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems